RECOMBINANT TRANSMEMBRANE DOMAIN-DEFICIENT STING AS BIOMIMETIC PROTEIN CARRIER FOR CGAMP ENHANCED CANCER IMMUNOTHERAPY
申请人:Northeastern University
公开号:US20210277077A1
公开(公告)日:2021-09-09
Disclosed are compositions comprising a fusion protein and a STING agonist, wherein the fusion protein comprises STINGΔTM protein fused to a cell-penetrating domain or a nanobody to deliver STING agonists. Also disclosed are methods of treating cancer, which is achieved by a administering said compositions.